March 23, 2020 / 8:04 AM / 12 days ago

BRIEF-Celon Pharma Signs Framework Agreement To Start Development Programme For Covid-19 Therapy

March 23 (Reuters) - Celon Pharma SA:

* SIGNS FRAMEWORK AGREEMENT WITH SIEC BADAWCZA LUKASIEWICZ TO START PROGRAM FOR DEVELOPMENT OF COVID-19 THERAPY

* UNDER PROGRAMME WORKS TO DETERMINE THERAUPETIC POTENTIAL OF KNOWN DRUGS AND ACTIVE SUBSTANCES AND THEIR IMPACT ON SARS COV-2 IN OTHER INDICATIONS THAN REGISTERED

* UNDER PROGRAMME PARTIES WORK ON DEVELOPING MOLECULES TARGETING ELEMENTS OF SARS COV-2 VIRUS

* UNDER AGREEMENT PARTIES TO SEEK STRATEGIC FINANCING FOR RESEARCH WORKS UNDER PROGRAMME Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below